Klamer D, ENGEL J, Svensson L. The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. Eur J Pharmacol. 2004;503:103-7 pubmed

Gowda C, Toomayan G, Qi W, Chen L, Cai Y, Allen D, et al. The effects of N(omega)-propyl-L-arginine on reperfusion injury of skeletal muscle. Nitric Oxide. 2004;11:17-24 pubmed

Fedorov R, Hartmann E, Ghosh D, Schlichting I. Structural basis for the specificity of the nitric-oxide synthase inhibitors W1400 and Nomega-propyl-L-Arg for the inducible and neuronal isoforms. J Biol Chem. 2003;278:45818-25 pubmed

Boer R, Ulrich W, Klein T, Mirau B, Haas S, Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol. 2000;58:1026-34 pubmed

Cooper G, Mialkowski K, Wolff D. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform. Arch Biochem Biophys. 2000;375:183-94 pubmed

Huang H, Martasek P, Roman L, Masters B, Silverman R. N(omega)-Nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase. J Med Chem. 1999;42:3147-53 pubmed

Lee Y, Marletta M, Martasek P, Roman L, Masters B, Silverman R. Conformationally-restricted arginine analogues as alternative substrates and inhibitors of nitric oxide synthases. Bioorg Med Chem. 1999;7:1097-104 pubmed

Zhang H, Fast W, Marletta M, Martasek P, Silverman R. Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine. J Med Chem. 1997;40:3869-70 pubmed